Modulation of the p53/MDM2 interplay by HAUSP inhibitors

Omid Tavana1,2, Wei Gu1,2,3

  • 1College of Physicians and Surgeons, Institute for Cancer Genetics, Columbia University, New York, NY 10032, USA.

Insights

The herpesvirus-associated ubiquitin-specific protease (HAUSP) regulates p53 stability. Inhibiting HAUSP increases p53 levels, offering potential cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • p53 and MDM2 are short-lived proteins regulated by ubiquitination-mediated degradation.
  • MDM2 E3 ligase activity and p53-MDM2 interaction are key regulatory mechanisms.
  • Emerging evidence highlights the critical role of deubiquitinase HAUSP (USP7) in this pathway.

Purpose of the Study:

  • To review advances in the p53-MDM2-HAUSP regulatory pathway.
  • To discuss positive and negative regulators of HAUSP activity.
  • To highlight HAUSP's role in cancer and the development of inhibitors.

Main Methods:

  • Literature review of studies on p53, MDM2, and HAUSP (USP7).
  • Analysis of regulatory mechanisms controlling HAUSP activity.
  • Examination of HAUSP's role in oncogenesis and therapeutic targeting.

Main Results:

  • HAUSP (USP7) deubiquitinase activity is critical for p53 regulation.
  • HAUSP inhibition enhances p53 protein stability.
  • This pathway's dysregulation is implicated in cancer development.

Conclusions:

  • HAUSP is a key regulator of p53 stability, distinct from MDM2's E3 ligase function.
  • Targeting HAUSP offers a promising therapeutic strategy for cancer.
  • The development of HAUSP inhibitors is a significant advancement in cancer therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K